title: Plasma concentrations of prolactin, noradrenaline, vasopressin and oxytocin during and after a prolonged epileptic seizure.
abstract: The time course and extent of changes in plasma prolactin, noradrenaline, vasopressin and oxytocin levels is reported following serial observations of a prolonged epileptic seizure arising in the temporal lobe, recorded by video-EEG-telemetry, in which the epileptic activity evolved from a simple partial to complex partial to secondarily generalised attack. The prolactin levels were markedly elevated during the phase of the simple partial seizure, at a time when consciousness was preserved, when motor activity was minimal and when EEG activity was highly localised. The hormonal levels continued to rise during the subsequent seizure evolution, suggesting that the duration (or intensity) of the seizure is an important, perhaps the most important, factor determining the degree of prolactin release during limbic seizures. Indeed, the prolactin elevation in this case (26 times the baseline level) is higher than any previously recorded, reflecting the unusual duration and intensity of this seizure. We did not observe the phenomenon of "exhaustion" of prolactin release and levels peaked after 49 min, and were high for over 2 h after the onset of the seizure, and after the convulsion had ceased. The concentrations of vasopressin, oxytocin and noradrenaline remained low during the aura, but rapidly increased during the phase of generalisation. The oxytocin and noradrenaline levels peaked during the phase of generalised convulsion, but the vasopressin levels peaked well into the post ictal phase, and remained high for several hours.(ABSTRACT TRUNCATED AT 250 WORDS)
authors: University Department of Clinical Neurology, Institute of Neurology, National Hospital, London, England.
authors: H
authors: H
authors: Meierkord
authors: S
authors: S
authors: Shorvon
authors: S L
authors: SL
authors: Lightman
mesh_terms: D000293:Adolescent; D004569:Electroencephalography; D004828:Epilepsies, Partial / Q000503:physiopathology*; D004833:Epilepsy, Temporal Lobe / Q000503:physiopathology*; D004830:Epilepsy, Tonic-Clonic / Q000503:physiopathology*; D005071:Evoked Potentials / Q000502:physiology; D005260:Female; D006801:Humans; D007031:Hypothalamus / Q000503:physiopathology; D008032:Limbic System / Q000503:physiopathology; D008991:Monitoring, Physiologic; D009433:Neural Inhibition / Q000502:physiology; D009638:Norepinephrine / Q000097:blood*; D010121:Oxytocin / Q000097:blood*; D011388:Prolactin / Q000097:blood*; D013702:Temporal Lobe / Q000503:physiopathology; D014667:Vasopressins / Q000097:blood*
chemical_list: D014667:Vasopressins; D010121:Oxytocin; D011388:Prolactin; D009638:Norepinephrine